Semax and Selank inhibit the enkephalin-degrading enzymes of human serum

Citation
Nv. Kost et al., Semax and Selank inhibit the enkephalin-degrading enzymes of human serum, RUS J BIOOR, 27(3), 2001, pp. 156-159
Citations number
20
Categorie Soggetti
Chemistry & Analysis
Journal title
RUSSIAN JOURNAL OF BIOORGANIC CHEMISTRY
ISSN journal
10681620 → ACNP
Volume
27
Issue
3
Year of publication
2001
Pages
156 - 159
Database
ISI
SICI code
1068-1620(200105/06)27:3<156:SASITE>2.0.ZU;2-Z
Abstract
Dose-dependent effect of synthetic heptapeptides Semax (Met-Glu-His-Phe-Pro -Gly-Pro) and Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro) on the enkephalin-degrad ing enzymes of human serum was demonstrated. The inhibitory effects of Sema x (IC50 10 muM) and Selank (IC50 20 muM) are more pronounced than that of p uromycin (IC50 10 mM), bacitracin, and some other inhibitors of peptidases. Beside the heptapeptides, their pentapeptide fragments also possessed an i nhibitory effect; tri-, tetra- and hexapeptide fragments did not display su ch an effect. As the above enzymes take part in degradation of not only enk ephalins but also other regulatory peptides, it can be assumed that one of the mechanisms of biological activity of Semax and Selank is related to thi s inhibitory activity of theirs.